KR-26556
KR-26556 is a sulfonamide type hepatitis B virus (HBV) capsid assembly regulator. KR-26556 exhibits anti-HBV activity with an EC50 of 0.04 μM. KR-26556 has favorable safety characteristics. KR-26556 can be used for research on chronic hepatitis B[1].
Product Specifications
CAS Number
2411762-66-6
UNSPSC
12352005
Target
HBV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(NC1=CC(F)=C(F)C(F)=C1)C2=CC(S(=O)(N3CCC(O)CC3)=O)=C(F)C=C2N
Molecular Formula
C18H17F4N3O4S
Molecular Weight
447.40
References & Citations
[1]Na HG, et al. Discovery of a New Sulfonamide Hepatitis B Capsid Assembly Modulator. ACS Med Chem Lett. 2020 Jan 9;11 (2) :166-171.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV727362 1.0 µg DNA
HCG4P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details 
213327-01 20 µL
SF3A1 (Splicing Factor 3A Subunit 1, PRP21, PRPF21, SAP114, SF3A120) discontinued
Sign In for Pricing
View Details 213327-02 100 µL
SF3A1 (Splicing Factor 3A Subunit 1, PRP21, PRPF21, SAP114, SF3A120) discontinued
Sign In for Pricing
View Details